↓ Skip to main content

PLOS

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

Overview of attention for article published in PLOS ONE, August 2012
Altmetric Badge

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
92 Mendeley
Title
A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria
Published in
PLOS ONE, August 2012
DOI 10.1371/journal.pone.0042284
Pubmed ID
Authors

Miriam K. Laufer, Phillip C. Thesing, Fraction K. Dzinjalamala, Osward M. Nyirenda, Rhoda Masonga, Matthew B. Laurens, Abbie Stokes-Riner, Terrie E. Taylor, Christopher V. Plowe

Abstract

The predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's withdrawal permits contemplation of re-introducing chloroquine for targeted uses. We aimed to compare the ability of different partner drugs to preserve chloroquine efficacy and prevent the re-emergence of resistance.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 3%
Unknown 89 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 18%
Student > Master 14 15%
Student > Ph. D. Student 9 10%
Student > Doctoral Student 7 8%
Student > Postgraduate 7 8%
Other 20 22%
Unknown 18 20%
Readers by discipline Count As %
Medicine and Dentistry 21 23%
Biochemistry, Genetics and Molecular Biology 12 13%
Agricultural and Biological Sciences 10 11%
Nursing and Health Professions 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 16 17%
Unknown 23 25%